No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Hikma’s Generic Version of Novo Nordisk’s Diabetes Drug Victoza® Approved and Launched in US
On 26 December 2024, Hikma Pharmaceuticals announced that it has received FDA approval for, and launched, its generic version of Novo Nordisk’s Victoza® (liraglutide) in the US in a 6mg/mL dosage form.